Suppr超能文献

采用多种本土 LC-MS 方法全面分析抗体药物偶联物曲妥珠单抗 deruxtecan。

A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.

机构信息

Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR 7178, Université de Strasbourg, CNRS, 67087 Strasbourg, France.

Infrastructure Nationale de Protéomique ProFI - FR2048, 67087 Strasbourg, France.

出版信息

Front Biosci (Landmark Ed). 2022 Oct 26;27(10):290. doi: 10.31083/j.fbl2710290.

Abstract

BACKGROUND

Native mass spectrometry (nMS) approaches appear attractive to complement bottom-up strategies traditionally used in biopharmaceutical industries thanks to their quite straightforward and rapid workflows, especially through online hyphenation of non-denaturing liquid chromatography (LC) to nMS. The present work provides an overview of the state-of-the-art chromatographic tools available for the detailed characterization of monoclonal antibody (mAb) formats, exemplified on the antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd).

METHODS

T-DXd was first characterized by conventional reversed phase LC (rpLC) and peptide mapping. Couplings of size exclusion chromatography (SEC), cation exchange chromatography (CEX), and hydrophobic interaction chromatography (HIC) to nMS were used to gain further insights into size, hydrophobic, and charge variants of T-DXd and its parental mAb trastuzumab, at intact and middle-up levels.

RESULTS

SEC-nMS first offered a direct snapshot of the homogeneous conjugation of T-DXd, with an average drug-to-antibody ratio (DAR) of 8 in agreement with a conjugation on cysteines after reduction of all interchain disulfide bonds. Moreover, SEC-nMS afforded precise identification and quantification of aggregates and fragments. Middle-up level experiments performed after IdeS digestion confirmed that drug conjugation occurs in the Fab region of the mAb, as seen with rpLC. HIC separated two DAR8 species that could not be differentiated by nMS. Although middle-up HIC-nMS proved to be more informative for oxidized forms, the identification of minor variants was still difficult because of poor MS signal quality, showing how the coupling of HIC to nMS remains challenging. Lastly, middle-up CEX-nMS provided accurate determination and localization of post-translational modifications, with several acidic/basic variants within Fab and Fc regions of T-DXd that were also identified by peptide mapping.

CONCLUSIONS

This study illustrates the strengths and drawbacks of each LC-nMS coupling. By combining SEC-, HIC-, and CEX-nMS, we were able to achieve a comprehensive characterization of T-DXd without extensive sample preparation prior to MS analysis.

摘要

背景

由于其相当简单和快速的工作流程,特别是通过非变性液相色谱(LC)与 nMS 的在线连接,天然质谱(nMS)方法似乎很有吸引力,可以补充传统上用于生物制药行业的自下而上的策略。本工作概述了用于详细表征单克隆抗体(mAb)结构的最新色谱工具,以抗体药物偶联物(ADC)曲妥珠单抗 deruxtecan(T-DXd)为例。

方法

首先通过常规反相 LC(rpLC)和肽图法对 T-DXd 进行表征。将尺寸排阻色谱(SEC)、阳离子交换色谱(CEX)和疏水相互作用色谱(HIC)与 nMS 联用,以获得 T-DXd 及其亲本 mAb 曲妥珠单抗的大小、疏水性和电荷变异体的进一步见解,在完整和中上水平。

结果

SEC-nMS 首先提供了 T-DXd 均匀缀合的直接快照,平均药物抗体比(DAR)为 8,与所有链间二硫键还原后在半胱氨酸上的缀合一致。此外,SEC-nMS 还提供了聚集体和片段的精确鉴定和定量。IdeS 消化后进行的中上水平实验证实,药物缀合发生在 mAb 的 Fab 区域,与 rpLC 所见相同。HIC 分离了两种无法通过 nMS 区分的 DAR8 物种。虽然中上水平 HIC-nMS 对于氧化形式更具信息性,但由于 MS 信号质量差,仍然难以识别较小的变异体,这表明 HIC 与 nMS 的结合仍然具有挑战性。最后,中上水平 CEX-nMS 提供了准确的测定和定位,T-DXd 的 Fab 和 Fc 区域内有几个酸性/碱性变体,也通过肽图法进行了鉴定。

结论

本研究说明了每种 LC-nMS 偶联的优缺点。通过 SEC-、HIC-和 CEX-nMS 的组合,我们能够在无需在 MS 分析前进行广泛的样品制备的情况下,实现对 T-DXd 的全面表征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验